Cancer Research Institute, Hengyang Medical College of University of South China, Hengyang 421001, Hunan Province, China.
Hengyang Medical College of University of South China, Hengyang 421001, Hunan Province, China.
Curr Mol Pharmacol. 2019;12(4):324-333. doi: 10.2174/1874467212666190719120446.
AIMS: The aim is to study the role of miR-675-5p coded by long non-coding RNA H19 in the development of Nasopharyngeal Cancer (NPC) and whether miR-675-5p regulates the invasion and metastasis of NPC through targeting SFN (14-3-3σ). The study further validated the relationship between H19, miR-675-5p and SFN in NPC and their relationship with the invasion and metastasis of NPC. METHODS: Western blot was used to detect the expression of 14-3-3σ protein in immortalized normal nasopharyngeal epithelial cells NP69 and different metastatic potential NPC cells, 6-10B and 5-8F. At the same time, to find out the relationship between 14-3-3σ protein and the expression of H19 and miR-675-5p, the expression of H19 and miR-675-5p in normal nasopharynx epithelial cells NP69 and varied nasopharyngeal carcinoma cells 6-10B and 5-8F were quantified by real-time PCR. MiR-675-5p mimic and inhibitor were transfected into NPC 6-10B to over-express and down-express miR-675-5p; miR-675-5p mimic negative control and inhibitor negative control were transfected into NPC 6-10B as control groups. The effect of over-expression and down-expression by miR-675-5p on the expression of 14-3-3σ protein was detected by Western blotting. The 3'-UTR segments of SFN, containing miR-675-5p binding sites were amplified by PCR and the luciferase activity in the transfected cells was assayed to detect whether SFN is the direct target of miR-675-5p. Transwell and scratch assays were used to verify the changes in NPC invasion and metastasis ability of mimics and inhibitors transfected with miR-675-5p. RESULTS: The expression of 14-3-3σ protein in normal nasopharynx epithelial cells NP69 is significantly higher than in varied nasopharyngeal carcinoma cells, 6-10B and 5-8F (P<0.05), and the 14-3-3σ protein levels in low-metastatic nasopharyngeal carcinoma cell 6-10B is higher than in high-metastatic nasopharyngeal carcinoma cell 5-8F. The expression of H19 and miR-675-5p are significantly higher in NPC cells than in NP69 cell (P<0.05). The expression of H19 and miR-675-5p in high-Metastatic nasopharyngeal carcinoma cell 5-8F was higher than in low-Metastatic nasopharyngeal carcinoma cell 6-10B. The expression of 14-3-3σ protein in miR-675-5p mimic cells was significantly lower than in mimic NC (negative control) group and blank control group. However, compared with the blank control group, mimic NC showed no significant difference in 14-3-3σ protein between the two groups. The miR-675-5p inhibitor group was significantly higher than the inhibitor NC group and the blank control group (p<0.05), but there was no significant difference in the expression of 14-3-3σ protein in the inhibitor NC group and the blank control group (p>0.05). Dual-luciferase reporter assay system shows the 3'-UTR segments of SFN containing miR-675-5p binding sites. SFN was the target gene of miR-675-5p. CONCLUSION: 14-3-3σ is downregulated in NPC and is involved in the development of NPC. H19 and miR- 675-5p are upregulated in NPC, which is related to the development of NPC. The over-expression of miR- 675-5p inhibits the expression of 14-3-3σ protein. SFN is the target gene of miR-675-5p. MiR-675-5p targets SFN, downregulates its protein expression and promotes the invasion and metastasis of NPC.
目的:本研究旨在探讨长链非编码 RNA H19 编码的 miR-675-5p 在鼻咽癌(NPC)发展中的作用,以及 miR-675-5p 是否通过靶向 SFN(14-3-3σ)调节 NPC 的侵袭和转移。本研究进一步验证了 H19、miR-675-5p 和 SFN 在 NPC 中的关系及其与 NPC 侵袭和转移的关系。
方法:Western blot 检测永生化正常鼻咽上皮细胞 NP69 和不同转移潜能 NPC 细胞 6-10B、5-8F 中 14-3-3σ 蛋白的表达。同时,为了找出 14-3-3σ 蛋白与 H19 和 miR-675-5p 表达的关系,用实时 PCR 定量检测正常鼻咽上皮细胞 NP69 和不同鼻咽癌细胞 6-10B、5-8F 中 H19 和 miR-675-5p 的表达。将 miR-675-5p 模拟物和抑制剂转染入 NPC 6-10B 中以过表达和下调 miR-675-5p;将 miR-675-5p 模拟物阴性对照和抑制剂阴性对照转染入 NPC 6-10B 作为对照组。Western blot 检测 miR-675-5p 过表达和下调对 14-3-3σ 蛋白表达的影响。通过 PCR 扩增包含 miR-675-5p 结合位点的 SFN 3'-UTR 片段,并检测转染细胞中的荧光素酶活性,以检测 SFN 是否为 miR-675-5p 的直接靶标。通过 Transwell 和划痕实验验证转染 miR-675-5p 模拟物和抑制剂后 NPC 侵袭和转移能力的变化。
结果:正常鼻咽上皮细胞 NP69 中 14-3-3σ 蛋白的表达明显高于不同鼻咽癌细胞 6-10B 和 5-8F(P<0.05),低转移潜能鼻咽癌细胞 6-10B 中 14-3-3σ 蛋白水平高于高转移潜能鼻咽癌细胞 5-8F。NPC 细胞中 H19 和 miR-675-5p 的表达明显高于 NP69 细胞(P<0.05)。高转移潜能鼻咽癌细胞 5-8F 中 H19 和 miR-675-5p 的表达高于低转移潜能鼻咽癌细胞 6-10B。miR-675-5p 模拟物细胞中 14-3-3σ 蛋白的表达明显低于模拟物 NC(阴性对照)组和空白对照组。然而,与空白对照组相比,模拟物 NC 两组间 14-3-3σ 蛋白无显著差异。miR-675-5p 抑制剂组明显高于抑制剂 NC 组和空白对照组(p<0.05),但抑制剂 NC 组和空白对照组 14-3-3σ 蛋白表达无显著差异(p>0.05)。双荧光素酶报告基因检测系统显示含有 miR-675-5p 结合位点的 SFN 3'-UTR 片段。SFN 是 miR-675-5p 的靶基因。
结论:14-3-3σ 在 NPC 中下调,参与 NPC 的发生发展。H19 和 miR-675-5p 在 NPC 中上调,与 NPC 的发生发展有关。miR-675-5p 的过表达抑制 14-3-3σ 蛋白的表达。SFN 是 miR-675-5p 的靶基因。miR-675-5p 靶向 SFN,下调其蛋白表达,促进 NPC 的侵袭和转移。
Eur Rev Med Pharmacol Sci. 2019-1
Curr Mol Pharmacol. 2019
Eur Rev Med Pharmacol Sci. 2018-10
BMC Cancer. 2019-11-28
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011-7
Asian Pac J Cancer Prev. 2013
Cancer Cell Int. 2025-7-16
Yale J Biol Med. 2023-12
Front Cell Dev Biol. 2022-8-24